Moderna says it will file Monday for emergency approval of its coronavirus vaccine

The company is just one of three that has a vaccine on the verge of federal approval that could lead to vaccinations in the U.S. in the coming weeks or months.

Updated: November 30, 2020 - 10:32am

Moderna said Monday that the biotechnology company will file for emergency approval of its coronavirus vaccine. The company says its vaccine has shown 94% effectiveness in late-stage clinical trials. 

The company is just one of three that has a vaccine that has recently shown at least 90% effectiveness.

American pharmaceutical company Pfizer and German firm BioTech are also seeking FDA approval that could come as early as next month. Astra Zeneca recently said its vaccine was 90% effective in recent clinical trials. 

Just the News Spotlight